Body size and risk of multiple myeloma in the Black Women’s Health Study
British Journal of Cancer, Published online: 12 January 2024; doi:10.1038/s41416-023-02571-wBody size and risk of multiple myeloma in the Black Women’s Health Study (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 12, 2024 Category: Cancer & Oncology Authors: Yachana Kataria Bala Niharika Pillalamarri Gary Zirpoli Raphael Szalat Julie R. Palmer Kimberly A. Bertrand Source Type: research
Minimum latency effects for cancer associated with exposures to radiation or other carcinogens
British Journal of Cancer, Published online: 11 January 2024; doi:10.1038/s41416-023-02544-zMinimum latency effects for cancer associated with exposures to radiation or other carcinogens (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 11, 2024 Category: Cancer & Oncology Authors: Mark P. Little Markus Eidem üller J. Christian Kaiser A. Iulian Apostoaei Source Type: research
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer
British Journal of Cancer, Published online: 11 January 2024; doi:10.1038/s41416-023-02572-9Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 11, 2024 Category: Cancer & Oncology Authors: Xiaohe Su Kaifeng Jin Qiji Guo Ziyue Xu Zhaopei Liu Han Zeng Yiwei Wang Yu Zhu Le Xu Zewei Wang Yuan Chang Jiejie Xu Source Type: research
Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a ‘liquid gold’ biopsy
British Journal of Cancer, Published online: 11 January 2024; doi:10.1038/s41416-023-02548-9Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a ‘liquid gold’ biopsy (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 11, 2024 Category: Cancer & Oncology Authors: Susannah M. Hallal Ágota Tűzesi Liam A. Sida Elissa Xian Daniel Madani Krishna Muralidharan Brindha Shivalingam Michael E. Buckland Laveniya Satgunaseelan Kimberley L. Alexander Source Type: research
Intratumoral presence of the genotoxic gut bacteria pks+ E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer
British Journal of Cancer, Published online: 10 January 2024; doi:10.1038/s41416-023-02554-xIntratumoral presence of the genotoxic gut bacteria pks+ E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 10, 2024 Category: Cancer & Oncology Authors: Jihoon E. Joo Yen Lin Chu Peter Georgeson Romy Walker Khalid Mahmood Mark Clendenning Aaron L. Meyers Julia Como Sharelle Joseland Susan G. Preston Natalie Diepenhorst Julie Toner Danielle J. Ingle Norelle L. Sherry Andrew Metz Brigid M. Lynch Roger L. Mi Source Type: research
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
British Journal of Cancer, Published online: 10 January 2024; doi:10.1038/s41416-023-02525-2Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 10, 2024 Category: Cancer & Oncology Authors: Michael D. Hogarty David S. Ziegler Andrea Franson Yueh-Yun Chi Denice Tsao-Wei Kangning Liu Rohan Vemu Eugene W. Gerner Elizabeth Bruckheimer Anasheh Shamirian Beth Hasenauer Frank M. Balis Susan Groshen Murray D. Norris Michelle Haber Julie R. Park Kath Source Type: research
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies
British Journal of Cancer, Published online: 09 January 2024; doi:10.1038/s41416-023-02561-yOleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 9, 2024 Category: Cancer & Oncology Authors: Ester Blanco Noelia Silva-Pilipich Ana Bocanegra Luisa Chocarro Antonio Procopio Karina Aus ín Joaqu ín Fernandez-Irigoyen Leticia Fern ández Nerea Razquin Ana Igea Maider Garnica Miriam Echaide Hugo Arasanz Ruth Vera David Escors Cristian Smerdou Graz Source Type: research
Med23 deficiency reprograms the tumor microenvironment to promote lung tumorigenesis
British Journal of Cancer, Published online: 09 January 2024; doi:10.1038/s41416-023-02556-9Med23 deficiency reprograms the tumor microenvironment to promote lung tumorigenesis (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 9, 2024 Category: Cancer & Oncology Authors: Xiaobo Fu Siming Liu Dan Cao Chonghui Li Hongbin Ji Gang Wang Source Type: research
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer
British Journal of Cancer, Published online: 09 January 2024; doi:10.1038/s41416-023-02560-zAutoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 9, 2024 Category: Cancer & Oncology Authors: Chae Young Han Jacob S. Bedia Wei-Lei Yang Sarah J. Hawley Lindsay Bergan Marika Hopper Joseph Celestino Jing Guo Terrie G. Gornet Antoninus Soosaipillai Hailing Yang Samantha D. Doskocil Anna E. Lokshin Beverly C. Handy Eleftherios P. Diamandis Richard G Source Type: research
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
British Journal of Cancer, Published online: 08 January 2024; doi:10.1038/s41416-023-02563-wDynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist? (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 8, 2024 Category: Cancer & Oncology Authors: D ébora Contreras-Toledo Paula Jim énez-Fonseca Carlos L ópez López Ana Fern ández Montes Ana Mar ía López Muñoz Francisca V ázquez Rivera Vicente Alonso Julia Alcaide Francesc Salv à Marta Covela R úa M ónica Guillot Alfonso Mart ín Carnicer Source Type: research
Systemic anticancer therapy for urothelial carcinoma: UK oncologists’ perspective
British Journal of Cancer, Published online: 08 January 2024; doi:10.1038/s41416-023-02543-0Systemic anticancer therapy for urothelial carcinoma: UK oncologists’ perspective (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 8, 2024 Category: Cancer & Oncology Authors: Robert J. Jones Simon J. Crabb Mark Linch Alison J. Birtle John McGrane Deborah Enting Robert Stevenson Kin Liu Bihani Kularatne Syed A. Hussain Source Type: research
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
British Journal of Cancer, Published online: 08 January 2024; doi:10.1038/s41416-023-02521-6Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 8, 2024 Category: Cancer & Oncology Authors: Fabian St ögbauer Susanne Beck Iordanis Ourailidis Jochen Hess Christopher Poremba Maren Lauterbach Barbara Wollenberg Anna Maria Stefanie Buchberger Moritz Jesinghaus Peter Schirmacher Albrecht Stenzinger Wilko Weichert Melanie Boxberg Jan Budczies Source Type: research
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity
British Journal of Cancer, Published online: 06 January 2024; doi:10.1038/s41416-023-02546-xEGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 6, 2024 Category: Cancer & Oncology Authors: Fenglin Cai Xiuding Yang Gang Ma Pengliang Wang Mengmeng Zhang Nannan Zhang Rupeng Zhang Han Liang Yongzhan Nie Cheng Dong Jingyu Deng Source Type: research
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE
British Journal of Cancer, Published online: 06 January 2024; doi:10.1038/s41416-023-02564-9Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 6, 2024 Category: Cancer & Oncology Authors: Claire Gouriou Claire Lemanski Pascal Pommier Karine Le Malicot Ang élique Saint Eleonor Rivin del Campo C écile Evin Laurent Quero Pauline Regnault Nabil Baba-Hamed Philippe Ronchin Gilles Crehange David Tougeron Elodie Menager-Tabourel Olivia Diaz Mic Source Type: research
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane
British Journal of Cancer, Published online: 05 January 2024; doi:10.1038/s41416-023-02549-8p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane (Source: British Journal of Cancer)
Source: British Journal of Cancer - January 5, 2024 Category: Cancer & Oncology Authors: H élène Vanacker Isabelle Treilleux Camille Schiffler Ivan Bieche Mario Campone Anne Patsouris Monica Arnedos Paul H. Cottu Jean-Philippe Jacquin Florence Dalenc Antoine Pinton Nicolas Servant Val éry Attignon Etienne Rouleau Alain Morel Fran çois Leg Source Type: research
